Tizon, Candido T.
HRN: 14-84-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/27/2024
07/04/2024
IV DRIP
500mg
OD
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes